Among 193 lung cancer patients from the non-coal-producing areas, 65 patients harbored TP53 gene mutations (33.68%), and nineteen counts G > T point mutations were detected in 65 patients (29.23%) (data not shown). The gene discussed is TP53; the disease is lung carcinoma.